A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Parameter name | |||||||||||||||||||||||||
2 | ||||||||||||||||||||||||||
3 | Intervention parameters | Unit | Source | Notes | ||||||||||||||||||||||
4 | No. of women of reproductive age reached | 2240000.00 | No. | Info from FEM (note that FEM has especially low cost per person): Freedom Radio reaches 5.6 million listeners (based on third party eval, freedom radio says they reach 10 million), 40% of which are women of reproductive age. I used estimates based off of their Kano campaign only. | Assumptions and limitations | |||||||||||||||||||||
5 | Effect of radio intervention (% fewer births per year in treatment vs. control) | 0.10 | % | This is based on RCT in Burkina Faso, from DMI | ||||||||||||||||||||||
6 | Generalisability discount | 0.25 | Proportion | I discounted for generalisability: I am uncertain about this value. Survey data is from women who live in rural areas, <5km from health facility, in villages without electricty access. I think these factors likely limit generalisability to Kano. | * Does not include additional benefits inc economic benefits, health benefits beyond avoiding fistula (such as avoiding postpartum depression, hypertension, etc), benefits to future children (from larger birth spacing) and wellbeing benefits from women's empowerment. | |||||||||||||||||||||
7 | Average no. of births per year per woman of repro age in Kano | 0.19 | No. | DHS Nigeria 2018 data | * Does not include government costs of providing contraception. | |||||||||||||||||||||
8 | Maternal mortality ratio | 0.01 | Proportion | From Kano state data; this includes deaths from unsafe abortion as well as pregnancy complications | * Super rough way of estimating long-term effects, the probabilites of each scenario are subjective estimates. | |||||||||||||||||||||
9 | Fistula prevalence | 0.43 | Percentage | https://www.sciencedirect.com/science/article/pii/S2214109X14703481 | * Not sure how benefits stack up year on year (aka how much of audience in a given year is the same as the last year's audience?) Didn't spend much time here since it has relatively minor effect on overall CE | |||||||||||||||||||||
10 | Mean number of children for someone with fistula | 3.10 | No. | https://www.sciencedirect.com/science/article/pii/S2214109X14703481 | * Note this is for FEM's current operations in Kano. Benefits are likely to be less in areas with lower maternal mortality (but would obv have to be significantly less to become non cost-effective). | |||||||||||||||||||||
11 | Percentage fistulas that are due to pregnancy | 71.40 | Percentage | https://www.sciencedirect.com/science/article/pii/S2214109X14703481 | ||||||||||||||||||||||
12 | Disability weight fistula | 0.59 | No. | GBD | This is the average disability weight from rectovaginal fistula and vesicovaginal fistula | |||||||||||||||||||||
13 | Average length of time using contraception | 1.96 | Years | This is quite rough. From paper, most of the women who use contraception at baseline were using implants (~51%), while some were using injectables (~37%) and others were using pills (~9%). I assumed that the average implant lasts around 3 years, and that the women on injectables or pills would use them for around 1 year, then did a weighted average. | ||||||||||||||||||||||
14 | ||||||||||||||||||||||||||
15 | Calculations | |||||||||||||||||||||||||
16 | Total number fewer births per year | 42560.00 | No. | |||||||||||||||||||||||
17 | Reduction in average no. of births per year in Kano | 0.02 | Proportion | |||||||||||||||||||||||
18 | Total fewer births (with generalisability discount) | 31920.00 | No. | I am discounting by 40% from burkina faso RCT | ||||||||||||||||||||||
19 | Deaths averted | 183.86 | No. | |||||||||||||||||||||||
20 | Chance of fistula per pregnancy | 0.001 | No. | Fistula prevalence x percentage of fistulas that are due to pregnancy/ average number of children for a person with a fistula | ||||||||||||||||||||||
21 | Reduction in number of women suffering from fistulas | 31.32 | No. | Chance of fistula per pregnancy x number of averted pregnancies | ||||||||||||||||||||||
22 | ||||||||||||||||||||||||||
23 | Costs | |||||||||||||||||||||||||
24 | Total costs | 400000.00 | $ | From email with Anna Christina. This is their approximate cost from campaign in Kano. | ||||||||||||||||||||||
25 | ||||||||||||||||||||||||||
26 | Worst case scenario: effects for one year only | |||||||||||||||||||||||||
27 | DALY avoided by averting fistulas | 18.56 | DALYS | |||||||||||||||||||||||
28 | DALY equivalents avoided by averting maternal deaths | 7556.61 | DALY-equivalents | |||||||||||||||||||||||
29 | Total no. DALYs avoided (DALY total per year x length of time using contraception) | 14847.33 | DALY-equivalents | |||||||||||||||||||||||
30 | Total no. WELLBYs, inc discount | 54935.13 | WELLBY-equivalents | Using 1 DALY = 3.7 WELLBY conversion | ||||||||||||||||||||||
31 | $/ WELLBY | 7.28 | $/WELLBY | |||||||||||||||||||||||
32 | GD multiples | 22.52 | GDX | 164/$ WELLBY for GD | This includes discount for generalisability from Burkina Faso trial | |||||||||||||||||||||
33 | Probability that this occurs | 0.70 | Probability | This is rough, subjective estimate. For full investigation, would use different weigh to weight probabilites | ||||||||||||||||||||||
34 | ||||||||||||||||||||||||||
35 | Best case scenario: effects over 8 years (if contraceptive accesss/ knowledge became new social norm) | |||||||||||||||||||||||||
36 | Discount rate | 0.08 | rate | I put the discount rate higher than usual, because i think contraceptive access/ knowledge will increase even without this intervention | ||||||||||||||||||||||
37 | DALYs avoided by averting fistulas | 115.17 | DALYs | |||||||||||||||||||||||
38 | DALY equivalents by averting maternal deaths | 46899.14 | DALY-equivalents | |||||||||||||||||||||||
39 | Total no. WELLBY equivalents | 173952.93 | WELLBY-equivalents | Using 1 DALY = 3.7 WELLBY conversion | ||||||||||||||||||||||
40 | $/WELLBY | 2.30 | $/WELLBY | |||||||||||||||||||||||
41 | Years of effectiveness | 8.00 | years | I assume that within 10 years time, even without this intervnetion there would be widespread contraceptive knowledge/ access | ||||||||||||||||||||||
42 | GD multiples | 71.32 | GDX | |||||||||||||||||||||||
43 | Probability that this occurs | 0.05 | Probability | Note: I think it's unlikely, but not impossibly so, that new contraceptive knowledge/ behavior establishes self as new social norm | ||||||||||||||||||||||
44 | ||||||||||||||||||||||||||
45 | Medium scenario: strongly diminuishing effects over 4 years | |||||||||||||||||||||||||
46 | Discount rate | 0.60 | rate | Assuming strongly diminuishing effects | ||||||||||||||||||||||
47 | DALYs avoided by averting fistulas | 41.93 | DALYs | |||||||||||||||||||||||
48 | DALY equivalents by averting maternal deaths | 17076.17 | DALY-equivalents | |||||||||||||||||||||||
49 | Total no. WELLBYs | 63337.00 | WELLBYs | Using 1 DALY = 3.7 WELLBY conversion | ||||||||||||||||||||||
50 | $/WELLBY | 6.32 | $/WELLBY | |||||||||||||||||||||||
51 | Years of effectiveness | 4.00 | years | |||||||||||||||||||||||
52 | GD multiples | 25.97 | GDX | |||||||||||||||||||||||
53 | Probability that this occurs | 0.25 | probability | Note: I think it's unlikely, but not impossibly so, that new contraceptive knowledge/ behavior establishes self as new social norm | ||||||||||||||||||||||
54 | ||||||||||||||||||||||||||
55 | Overall cost-effectiveness | 25.82 | GDX | |||||||||||||||||||||||
56 | ||||||||||||||||||||||||||
57 | ||||||||||||||||||||||||||
58 | ||||||||||||||||||||||||||
59 | ||||||||||||||||||||||||||
60 | ||||||||||||||||||||||||||
61 | ||||||||||||||||||||||||||
62 | ||||||||||||||||||||||||||
63 | ||||||||||||||||||||||||||
64 | ||||||||||||||||||||||||||
65 | ||||||||||||||||||||||||||
66 | ||||||||||||||||||||||||||
67 | ||||||||||||||||||||||||||
68 | ||||||||||||||||||||||||||
69 | ||||||||||||||||||||||||||
70 | ||||||||||||||||||||||||||
71 | ||||||||||||||||||||||||||
72 | ||||||||||||||||||||||||||
73 | ||||||||||||||||||||||||||
74 | ||||||||||||||||||||||||||
75 | ||||||||||||||||||||||||||
76 | ||||||||||||||||||||||||||
77 | ||||||||||||||||||||||||||
78 | ||||||||||||||||||||||||||
79 | ||||||||||||||||||||||||||
80 | ||||||||||||||||||||||||||
81 | ||||||||||||||||||||||||||
82 | ||||||||||||||||||||||||||
83 | ||||||||||||||||||||||||||
84 | ||||||||||||||||||||||||||
85 | ||||||||||||||||||||||||||
86 | ||||||||||||||||||||||||||
87 | ||||||||||||||||||||||||||
88 | ||||||||||||||||||||||||||
89 | ||||||||||||||||||||||||||
90 | ||||||||||||||||||||||||||
91 | ||||||||||||||||||||||||||
92 | ||||||||||||||||||||||||||
93 | ||||||||||||||||||||||||||
94 | ||||||||||||||||||||||||||
95 | ||||||||||||||||||||||||||
96 | ||||||||||||||||||||||||||
97 | ||||||||||||||||||||||||||
98 | ||||||||||||||||||||||||||
99 | ||||||||||||||||||||||||||
100 |